NT-proBNP is a key cardiac marker for a broad array of cardiovascular conditions, including the diagnosis and management of heart failure, and risk stratification of patients with acute coronary syndrome.
Lars Gunneflo, CEO of Amic, said: “The NT-proBNP test will be one of the first to be launched on our Forecast POC diagnostic system.”